EXPD vs REPL
Expeditors International of Washington, Inc. (EXPD) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
REPL does not have a complete income-statement cache yet.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. REPL currently screens at market cap $825.7M.
Not investment advice. Open the EXPD and REPL stock pages for the full models.
Not investment advice.